MicroRNA Global Market Report 2024

Description

MicroRNAs, small RNA molecules that do not code for proteins and typically span about 20-22 nucleotides in length, serve as regulators of gene expression. They achieve this by binding to complementary sequences on messenger RNA (mRNA) molecules, typically resulting in gene silencing through translational repression or target degradation.

The primary products related to microRNAs include instruments and consumables. MicroRNA instruments encompass the tools and equipment utilized for microRNA analysis, such as microarray scanners and PCR machines. Various assay types involved include immunoassays, next-generation sequencing, miRNA arrays, and PCR-based arrays, applied in cancer, infectious diseases, immunological disorders, cardiovascular diseases, neurological diseases, and other applications. These are employed by academic and research institutes, biopharmaceutical companies, diagnostic centers, and clinical research organizations.

The microRNA market research report is one of a series of new reports from The Business Research Company that provides microRNA market statistics, including microRNA industry global market size, regional shares, competitors with microRNA market share, detailed microRNA market segments, market trends, and opportunities, and any further data you may need to thrive in the microRNA industry. This microRNA market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microRNA market size has grown rapidly in recent years. It will grow from $1.12 billion in 2023 to $1.33 billion in 2024 at a compound annual growth rate (CAGR) of 18.3%. The historical growth can be attributed to the discovery of microRNAs, RNA interference (RNAi), genome sequencing projects, computational biology and bioinformatics, and research on extracellular vehicles (EVs).

The microRNA market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2028 at a compound annual growth rate (CAGR) of 18.6%. The anticipated growth in the forecast period can be attributed to clinical translation, regulatory networks and systems biology, microRNA-based therapeutics, therapeutic potential, and biomarker discovery. Significant trends expected in the forecast period encompass technological advances, bioinformatics and data analysis, cross-species conservation, microbiome interactions, and functional mechanisms.

The rising incidence of cancer cases is poised to drive the expansion of the microRNA market in the foreseeable future. Cancer, a multifaceted ailment characterized by uncontrolled cell proliferation, often culminates in the development of malignant tumors that can infiltrate nearby tissues and metastasize to distant organs, posing significant health hazards. The escalating number of cancer cases stems from diverse factors, including aging demographics, lifestyle behaviors such as smoking and unhealthy dietary habits, environmental toxins, and enhanced diagnostic techniques facilitating early detection. MicroRNA, when combined with conventional cancer treatments, augments drug sensitivity and enhances treatment outcomes. Beyond therapy, miRNAs function as diagnostic and prognostic biomarkers, aiding in cancer type identification, prognosis prediction, and treatment response monitoring. For example, in May 2024, as reported by the National Cancer Institute, an estimated 20 million new cancer cases and 9.7 million cancer-related deaths occurred annually in 2022, with projections indicating a rise to 15.3 million deaths and 29.9 million new cases per year by 2040. Consequently, the mounting incidence of cancer cases propels the growth of the microRNA market.

Prominent entities in the microRNA market are directing their efforts towards developing cutting-edge solutions, such as MiRNA probe customization services, to cater to the specific requirements of researchers and clinicians, enhance miRNA detection accuracy, and facilitate diverse applications. MiRNA probe customization services encompass specialized offerings provided by biotechnology and molecular biology firms to design and manufacture tailored probes targeting specific microRNAs (miRNAs) for various research and clinical purposes. For instance, in September 2023, Abnova Corporation, a biotechnology firm based in Taiwan, introduced enhanced services for customizing miRNA probes alongside a new array of cataloged miRNA probes to address the varied needs of academic, industrial, and research communities involved in miRNA studies. These probes play a critical role in identifying and precisely localizing miRNAs, which are small, non-coding RNA molecules essential for numerous biological processes. Abnova's customization services ensure high specificity and minimal cross-reactivity, rendering them suitable for analyzing samples with limited miRNA content.

In May 2021, Nexturn Bio Inc., a South Korea-based miRNA research and development (R&D) company, acquired a 50% stake in RosVivo Therapeutics Inc. for $5.5 million. Through this acquisition, Nexturn Bio Inc. aims to bolster its position as a bio-company by collaborating on the development of novel medication pipelines utilizing miRNA technology. RosVivo Therapeutics, Inc., based in the United States, specializes in the development of microRNA-based therapeutics.

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc, Sistemic Scotland Limited

North America was the largest region in the microRNA market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the MicroRNA market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microRNA market consists of revenues earned by entities by providing services such as microRNA sequencing and data analysis services, microRNA therapeutic development services, and microRNA profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The microRNA market also includes sales of microRNA extraction kits, microRNA detection kits, microRNA quantification kits, and microRNA expression arrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

MicroRNA Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microrna market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microrna? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microrna market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Products: Instruments; Consumables
2) By Assay Type: Immunoassay; Next Generation Sequencing; miRNA Arrays; Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer; Infectious Diseases; Immunological Disorder; Cardiovascular Disease; Neurological Disease; Other Applications
4) By End User: Academic And Research Institutes; Biopharmaceutical Companies; Diagnostic Centers; Clinical Research Organizations
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc; Kaneka Corporation; Illumina Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18174

1. Executive Summary

2. MicroRNA Market Characteristics

3. MicroRNA Market Trends And Strategies

4. MicroRNA Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global MicroRNA Market Size and Growth

5.1. Global MicroRNA Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global MicroRNA Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global MicroRNA Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. MicroRNA Market Segmentation

6.1. Global MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Consumables
6.2. Global MicroRNA Market, Segmentation By Assay Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Immunoassay
Next Generation Sequencing
miRNA Arrays
Polymerase Chain Reaction (PCR) Based Arrays
6.3. Global MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Other Applications
6.4. Global MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Academic And Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Clinical Research Organizations

7. MicroRNA Market Regional And Country Analysis

7.1. Global MicroRNA Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global MicroRNA Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific MicroRNA Market

8.1. Asia-Pacific MicroRNA Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China MicroRNA Market

9.1. China MicroRNA Market Overview
9.2. China MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India MicroRNA Market

10.1. India MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan MicroRNA Market

11.1. Japan MicroRNA Market Overview
11.2. Japan MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia MicroRNA Market

12.1. Australia MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia MicroRNA Market

13.1. Indonesia MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea MicroRNA Market

14.1. South Korea MicroRNA Market Overview
14.2. South Korea MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe MicroRNA Market

15.1. Western Europe MicroRNA Market Overview
15.2. Western Europe MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK MicroRNA Market

16.1. UK MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany MicroRNA Market

17.1. Germany MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France MicroRNA Market

18.1. France MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy MicroRNA Market

19.1. Italy MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain MicroRNA Market

20.1. Spain MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe MicroRNA Market

21.1. Eastern Europe MicroRNA Market Overview
21.2. Eastern Europe MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia MicroRNA Market

22.1. Russia MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America MicroRNA Market

23.1. North America MicroRNA Market Overview
23.2. North America MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA MicroRNA Market

24.1. USA MicroRNA Market Overview
24.2. USA MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada MicroRNA Market

25.1. Canada MicroRNA Market Overview
25.2. Canada MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America MicroRNA Market

26.1. South America MicroRNA Market Overview
26.2. South America MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil MicroRNA Market

27.1. Brazil MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East MicroRNA Market

28.1. Middle East MicroRNA Market Overview
28.2. Middle East MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa MicroRNA Market

29.1. Africa MicroRNA Market Overview
29.2. Africa MicroRNA Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa MicroRNA Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa MicroRNA Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. MicroRNA Market Competitive Landscape And Company Profiles

30.1. MicroRNA Market Competitive Landscape
30.2. MicroRNA Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck KGaA
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Agilent Technologies Inc
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Kaneka Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Illumina Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. MicroRNA Market Other Major And Innovative Companies

31.1. Bio-Rad Laboratories Inc.
31.2. QIAGEN N.V.
31.3. Miltenyi Biotec
31.4. LGC Limited
31.5. Promega Corporation
31.6. Abcam plc
31.7. Integrated DNA Technologies Inc.
31.8. NanoString Technologies Inc.
31.9. Biodynamics Laboratory Inc.
31.10. Horizon Discovery Ltd.
31.11. OriGene Technologies Inc.
31.12. Biogenex Laboratories
31.13. Omega Bio-Tek
31.14. New England Biolabs
31.15. Quantabio

32. Global MicroRNA Market Competitive Benchmarking

33. Global MicroRNA Market Competitive Dashboard

34. Key Mergers And Acquisitions In The MicroRNA Market

35. MicroRNA Market Future Outlook and Potential Analysis

35.1 MicroRNA Market In 2028 - Countries Offering Most New Opportunities
35.2 MicroRNA Market In 2028 - Segments Offering Most New Opportunities
35.3 MicroRNA Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer